Question 1

Does Grantham, Mayo, Van Otterloo own MRNA stock?

Accepted Answer

No. Grantham, Mayo, Van Otterloo exited its MRNA (Moderna) position in Q3 2025. Its Q2 2025 13F listed 255,018 shares worth $7M.

Question 2

How many shares of MRNA does Grantham, Mayo, Van Otterloo own?

Accepted Answer

None since Q3 2025, when Grantham, Mayo, Van Otterloo exited the position. Its Q2 2025 13F listed 255,018 shares worth $7M.

Question 3

What is Grantham, Mayo, Van Otterloo's MRNA position worth?

Accepted Answer

Grantham, Mayo, Van Otterloo's MRNA position was worth $7M in its Q2 2025 13F, before the exit in Q3 2025.

Question 4

Is Grantham, Mayo, Van Otterloo buying or selling MRNA?

Accepted Answer

In Q3 2025, Grantham, Mayo, Van Otterloo exited its entire MRNA position.

Question 5

When did Grantham, Mayo, Van Otterloo first buy MRNA?

Accepted Answer

Grantham, Mayo, Van Otterloo first reported MRNA in its Q1 2023 13F and listed it in 8 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q3 Latest	Exited	0	-100.0%	$0	0.0%	$25.33	0
2025-Q2	Decreased	255,018	-66.6%	$7M	0.0%	$27.16	0
2025-Q1	Increased	763,253	+39.3%	$21.6M	0.1%	$31.12	38
2024-Q4	New	547,812	—	$22.8M	0.1%	$39.38	39